Structured evidence table for Saw Palmetto Hair Loss Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Saw Palmetto Hair Loss Randomized Trial | p p p 2 By Day 180, the mean (SD) anterior terminal hair count in the active treatment group increased by 5.5 (23.8), whereas placebo fell below baseline by 180 days −2.5 (22.8) ( = NS). | 4 | Ablon Glynis (2026) | The Safety and Efficacy of a Novel Saw Palmetto ( Serenoa repens ) Extract for Promoting Hair Growth in Adults With Self‐Perceived Thinning Hair: 180‐Day Results |
| Saw Palmetto Hair Loss Randomized Trial | The largest mean growth effects were localized in posterior terminal hair count, which increased significantly by 13.0 (22.4) at Day 180 for the active group ( < 0.001), while the mean posterior terminal hair counts for the placebo group decreased by −7.6 (18.4). | 4 | Ablon Glynis (2026) | The Safety and Efficacy of a Novel Saw Palmetto ( Serenoa repens ) Extract for Promoting Hair Growth in Adults With Self‐Perceived Thinning Hair: 180‐Day Results |
| Saw Palmetto Hair Loss Randomized Trial | p p 2 The mean (SD) anterior vellus hair count from Day 0 increased by 3.6 (11.3) at Day 180 for subjects in the active treatment group and decreased by 3.9 (13.1) for subjects in the placebo group with a significant between‐group difference (7.46) in mean change in vellus hair counts at Day 180 ( < 0.05). | 4 | Ablon Glynis (2026) | The Safety and Efficacy of a Novel Saw Palmetto ( Serenoa repens ) Extract for Promoting Hair Growth in Adults With Self‐Perceived Thinning Hair: 180‐Day Results |
| Saw Palmetto Hair Loss Randomized Trial | Unfortunately, drug therapy for hair loss remains limited to oral or topical minoxidil for male pattern hair loss to which oral finasteride may be added, if necessary []. | 4 | Ablon Glynis (2026) | The Safety and Efficacy of a Novel Saw Palmetto ( Serenoa repens ) Extract for Promoting Hair Growth in Adults With Self‐Perceived Thinning Hair: 180‐Day Results |
| Saw Palmetto Hair Loss Randomized Trial | Patients/methods The active group showed significant improvement in terminal hair count from baseline in anterior (p Conclusion These preliminary results indicate the daily administration of a proprietary saw palmetto (Serenoa repens) extract safely and effectively promotes hair growth in men and women with self-perceived thinning hair. | 4 | Ablon G (2025) | The Safety and Efficacy of a Proprietary Bioactive Fatty Acids Extract From Saw Palmetto (Serenoa repens) for Promoting Hair Growth and Reducing Hair Loss in Adults With Self-Perceived Thinning Hair: 90-Day Results. |
| Saw Palmetto Hair Loss Randomized Trial | Aims This study assessed the efficacy and safety of a proprietary extract of bioactive fatty acids from saw palmetto for treating self-perceived thinning hair in healthy adult male and female subjects. | 4 | Ablon G (2025) | The Safety and Efficacy of a Proprietary Bioactive Fatty Acids Extract From Saw Palmetto (Serenoa repens) for Promoting Hair Growth and Reducing Hair Loss in Adults With Self-Perceived Thinning Hair: 90-Day Results. |
| Saw Palmetto Hair Loss Randomized Trial | Methods In this 6-month, randomized, double-blind, placebo-controlled study, subjects were randomized to receive active treatment (n = 40) or placebo (n = 20). | 4 | Ablon G (2025) | The Safety and Efficacy of a Proprietary Bioactive Fatty Acids Extract From Saw Palmetto (Serenoa repens) for Promoting Hair Growth and Reducing Hair Loss in Adults With Self-Perceived Thinning Hair: 90-Day Results. |
Source documents